Lectin-Galactoside Binding Soluble 3 (LGALS3) Antibody

Product Graph
559€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Lectin-Galactoside Binding Soluble 3 (LGALS3) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx025325
tested applications
ELISA, WB

Description

This product is currently in development. The lead time for this product may be several months. Please contact us at

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Lectin-Galactoside Binding Soluble 3 (LGALS3)
Host
Mouse
Reactivity
Human
Recommended Dilution
WB: 1/500 - 1/4000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1
Purification
Unpurified crude ascites.
Size 1
100 µl
Form
Liquid
Tested Applications
ELISA, WB
Buffer
Ascites containing 0.09% sodium azide.
Availability
Please enquire.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P17931
Background
Antibody anti-LGALS3
Status
RUO

Descripción

Related Products

FNab03316

LGALS3 antibody

Galectins are a family of animal lectins defined by shared characteristic amino-acid sequences and affinity for β-galactose-containing oligosac-charides(PMID: 8063692). Galectin-3 contains one carbohydrate recognition domain(CRD) and a proline-and glycine-rich N-terminal domain through which is able to form oligomers. Galectin-3 is widely expressed in many normal tissues and a variety of tumors.

Ver Producto
FNab03317

LGALS3 antibody

Galectins are a family of animal lectins defined by shared characteristic amino-acid sequences and affinity for β-galactose-containing oligosac-charides(PMID: 8063692). Galectin-3 contains one carbohydrate recognition domain(CRD) and a proline-and glycine-rich N-terminal domain through which is able to form oligomers. Galectin-3 is widely expressed in many normal tissues and a variety of tumors.

Ver Producto
P0718

Recombinant Human LGALS3

Ver Producto